Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral antidiabetic therapy].

S Schneider1, G Pazdzierny, H H Klein

  • 1Medizinische Klinik 1, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Germany. Stephan.Schneider@rub.de

Deutsche Medizinische Wochenschrift (1946)
|December 2, 2006
PubMed
Summary

Effective type 2 diabetes mellitus (2DM) management involves lifestyle changes and medication like metformin. Regular HbA1c monitoring guides treatment adjustments to prevent vascular complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy.

ESMO open·2021
Same author

[Insulin therapy-new insulin analogues].

Der Internist·2019
Same author

[Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].

Herz·2017
Same author

[Mild therapeutic hypothermia in cardiac arrest].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

[43-year-old woman with diabetes and postoperative circulatory collapse].

Deutsche medizinische Wochenschrift (1946)·2013

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Context:

  • Type 2 diabetes mellitus (2DM) management requires multifaceted strategies to prevent vascular complications.
  • Lifestyle modifications, including diet and exercise, form the cornerstone of antihyperglycemic therapy.

Purpose:

  • To outline current therapeutic approaches for managing type 2 diabetes mellitus (2DM).
  • To emphasize the importance of glycemic control, targeting HbA1c below 6.5%.

Summary:

  • Metformin is the primary oral agent for 2DM, with glinides offering dietary flexibility.
  • Combination therapy, including metformin with sulfonylureas, is increasingly accepted, supported by NICE guidelines.
  • Glitazones may offer benefits beyond glycemic control, warranting further research.
  • Insulin initiation is crucial when oral medications fail to achieve adequate blood sugar reduction.

Impact:

  • Optimized antihyperglycemic treatment strategies can mitigate the risk of vascular complications in 2DM patients.
  • Regular HbA1c monitoring facilitates timely therapeutic adjustments, improving patient outcomes.
  • Evidence-based treatment guidelines aid clinicians in selecting appropriate antihyperglycemic interventions.

Related Experiment Videos